MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)

NCT01643850 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Pigmented Villonodular Synovitis
PVNS
Giant Cell Tumor of the Tendon Sheath
GCCTS
Tenosynovial Giant Cell Tumor Localized or Diffused Type
GCTS

Interventions

DRUG: MCS110
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals